{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:29:04Z","timestamp":1767850144247,"version":"3.49.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000055","name":"US National Institute on Deafness and Communication Disorders","doi-asserted-by":"publisher","award":["R0108671"],"award-info":[{"award-number":["R0108671"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","award":["75D30119C06842, PI: M. P."],"award-info":[{"award-number":["75D30119C06842, PI: M. P."]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","award":["75D30121C12195"],"award-info":[{"award-number":["75D30121C12195"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Characterizing strains causing noninvasive and invasive pneumococcal disease (IPD) may inform the impact of new pneumococcal conjugate vaccines (PCVs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>During 2011\u20132019, among children aged 6\u201336 months, pneumococcal serotype distribution and antibiotic nonsusceptibility of nasopharyngeal and middle ear fluid (MEF) isolates collected at onset of acute otitis media (AOM) in Rochester, New York, were compared with IPD isolates from the Active Bacterial Core surveillance (ABCs) system across 10\u2005US sites.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From Rochester, 400 (nasopharyngeal) and 156 (MEF) pneumococcal isolates were collected from 259 children. From ABCs, 907 sterile-site isolates were collected from 896 children. Non-PCV serotypes 35B and 21 were more frequent among the Rochester AOM cases, while serotypes 3, 19A, 22F, 33F, 10A, and 12F contained in PCVs were more frequent among ABCs IPD cases. The proportion of antibiotic-nonsusceptible pneumococcal isolates was generally more common among IPD cases. In 2015\u20132019, serotype 35B emerged as the most common serotype associated with multiclass antibiotic nonsusceptibility for both the Rochester AOM and ABCs IPD cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Pneumococcal isolates from children in Rochester with AOM differ in serotype distribution and antibiotic susceptibility compared to IPD cases identified through US surveillance. Non-PCV serotype 35B emerged as a common cause of AOM and IPD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae184","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:28:40Z","timestamp":1712662120000},"page":"1243-1252","source":"Crossref","is-referenced-by-count":8,"title":["Pneumococci Isolated From Children in Community-Based Practice Differ From Isolates Identified by Population- and Laboratory-Based Invasive Disease Surveillance"],"prefix":"10.1093","volume":"230","author":[{"given":"Ravinder","family":"Kaur","sequence":"first","affiliation":[{"name":"Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute , Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Gierke","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"McGee","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute , Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8276-3938","authenticated-orcid":false,"given":"Michael","family":"Pichichero","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute , Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Active Bacterial Core Surveillance (ABCs) Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Reingold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica M","family":"Farley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee H","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Lynfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy M","family":"Angeles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabra","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Houston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A","family":"Khanlian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayvilynne","family":"Poblete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary Q","family":"Landis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Wester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Burzlaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget J","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemma V","family":"Rowlands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasha","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Keipp","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffanie M","family":"Markus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Mathoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirasol","family":"Apostol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Como-Sabetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Triden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Snippes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Glennen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"MacInnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Pilishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"2024111514525476600_jiae184-B1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024111514525476600_jiae184-B2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1473-3099(22)00526-6","article-title":"Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1\/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial","volume":"23","author":"Platt","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2024111514525476600_jiae184-B3","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1016\/j.vaccine.2022.05.079","article-title":"Phase 1\/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years","volume":"40","author":"Chichili","year":"2022","journal-title":"Vaccine"},{"key":"2024111514525476600_jiae184-B4","first-page":"1174","author":"Kobayashi"},{"key":"2024111514525476600_jiae184-B5","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"2024111514525476600_jiae184-B6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokinen","year":"2004","journal-title":"J Infect Dis"},{"key":"2024111514525476600_jiae184-B7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/cix895","article-title":"Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries","volume":"66","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024111514525476600_jiae184-B8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/mi.2014.55","article-title":"Antibody blocks acquisition of bacterial colonization through agglutination","volume":"8","author":"Roche","year":"2015","journal-title":"Mucosal Immunol"},{"key":"2024111514525476600_jiae184-B9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41385-019-0218-5","article-title":"Generation of protective pneumococcal-specific nasal resident memory CD4(+) T cells via parenteral immunization","volume":"13","author":"O\u2019Hara","year":"2020","journal-title":"Mucosal Immunol"},{"key":"2024111514525476600_jiae184-B10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"2024111514525476600_jiae184-B11","doi-asserted-by":"crossref","first-page":"e25558","DOI":"10.1371\/journal.pone.0025558","article-title":"Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation","volume":"6","author":"Cohen","year":"2011","journal-title":"PLoS One"},{"key":"2024111514525476600_jiae184-B12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/cid\/ciab990","article-title":"Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged \u226518 years","volume":"75","author":"Essink","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024111514525476600_jiae184-B13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10096-021-04324-0","article-title":"Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015\u20132019","volume":"41","author":"Kaur","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024111514525476600_jiae184-B14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/INF.0000000000001206","article-title":"Emerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to the 7-valent era, 2006\u20132015","volume":"35","author":"Kaur","year":"2016","journal-title":"Pediat Infect Dis J"},{"key":"2024111514525476600_jiae184-B15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciaa157","article-title":"Rising pneumococcal antibiotic resistance in the post-13-valent pneumococcal conjugate vaccine era in pediatric isolates from a primary care setting","volume":"72","author":"Kaur","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024111514525476600_jiae184-B16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2024111514525476600_jiae184-B17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/civ368","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children","volume":"61","author":"Olarte","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024111514525476600_jiae184-B18","doi-asserted-by":"crossref","first-page":"744742","DOI":"10.3389\/fcimb.2021.744742","article-title":"Transition of serotype 35B pneumococci from commensal to prevalent virulent strain in children","volume":"11","author":"Fuji","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2024111514525476600_jiae184-B19","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"2024111514525476600_jiae184-B20","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1017\/S0950268813003178","article-title":"Five-year prospective study of paediatric acute otitis media in Rochester, NY: modelling analysis of the risk of pneumococcal colonization in the nasopharynx and infection","volume":"142","author":"Friedel","year":"2014","journal-title":"Epidemiol Infect"},{"key":"2024111514525476600_jiae184-B21","doi-asserted-by":"crossref","first-page":"e20170181","DOI":"10.1542\/peds.2017-0181","article-title":"Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era","volume":"140","author":"Kaur","year":"2017","journal-title":"Pediatrics"},{"key":"2024111514525476600_jiae184-B22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.16.2.230-241.2003","article-title":"Importance of respiratory viruses in acute otitis media","volume":"16","author":"Heikkinen","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"2024111514525476600_jiae184-B23","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2024111514525476600_jiae184-B24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/jiac154","article-title":"Impact of pneumococcal conjugate vaccines on antibiotic-nonsusceptible invasive pneumococcal disease in the United States","volume":"226","author":"Bajema","year":"2022","journal-title":"J Infect Dis"},{"key":"2024111514525476600_jiae184-B25","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/jir052","article-title":"Shifting genetic structure of invasive serotype 19A pneumococci in the United States","volume":"203","author":"Beall","year":"2011","journal-title":"J Infect Dis"},{"key":"2024111514525476600_jiae184-B26","doi-asserted-by":"crossref","first-page":"60.e9","DOI":"10.1016\/j.cmi.2015.08.027","article-title":"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2024111514525476600_jiae184-B27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12864-017-4017-7","article-title":"Validation of beta-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences","volume":"18","author":"Li","year":"2017","journal-title":"BMC Genomics"},{"key":"2024111514525476600_jiae184-B28","volume-title":"Performance standards for antimicrobial susceptibility testing. 27th ed. CLSI supplement M100","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2017"},{"key":"2024111514525476600_jiae184-B29","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and children\u2014use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2024111514525476600_jiae184-B30","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2017.05.077","article-title":"Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts\u2019 children to relatively low invasiveness","volume":"35","author":"Yildirim","year":"2017","journal-title":"Vaccine"},{"key":"2024111514525476600_jiae184-B31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/INF.0000000000000849","article-title":"Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia","volume":"34","author":"Desai","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2024111514525476600_jiae184-B32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024111514525476600_jiae184-B33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1473-3099(18)30349-9","article-title":"Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey","volume":"18","author":"Ouldali","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024111514525476600_jiae184-B34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"key":"2024111514525476600_jiae184-B35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/14760584.2023.2162506","article-title":"Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines","volume":"22","author":"Pichichero","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"2024111514525476600_jiae184-B36","author":"Grant"},{"key":"2024111514525476600_jiae184-B37","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/INF.0b013e3182788fdd","article-title":"Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine","volume":"32","author":"Sharma","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2024111514525476600_jiae184-B38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3201\/eid2306.170071","article-title":"Invasive serotype 35B pneumococci including an expanding serotype switch lineage, United States, 2015\u20132016","volume":"23","author":"Chochua","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2024111514525476600_jiae184-B39","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.vaccine.2024.02.007","article-title":"Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK","volume":"42","author":"Hyams","year":"2024","journal-title":"Vaccine"},{"key":"2024111514525476600_jiae184-B40","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00706-5","article-title":"Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study [manuscript published online ahead of print 2 February 2024]","author":"Bertran","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2024111514525476600_jiae184-B41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"Moore","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024111514525476600_jiae184-B42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/s12879-014-0640-y","article-title":"Correlation of nasopharyngeal cultures prior to and at onset of acute otitis media with middle ear fluid cultures","volume":"14","author":"Kaur","year":"2014","journal-title":"BMC Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae184\/57354559\/jiae184.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/5\/1243\/60683750\/jiae184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/5\/1243\/60683750\/jiae184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T14:53:14Z","timestamp":1731682394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/5\/1243\/7642459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,9]]},"published-print":{"date-parts":[[2024,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae184","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11,15]]},"published":{"date-parts":[[2024,4,9]]}}}